Oncogenic <i>NTRK3</i> mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemia

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2025-02-13
DOI
https://doi.org/10.3324/haematol.2024.285572
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Oncogenic NTRK3 mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemia

Paul Piehowski, Cristina E. Tognon, Camilo Posso, Karl Weitz et al.
Haematologica
Lung Cancer Treatments and Mutations
article

Oncogenic NTRK3 mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemia

Paul Piehowski, Cristina E. Tognon, Camilo Posso, Karl Weitz, Janét Pittsenbarger, Brian Druker, Nicola Long, Richard D. Press, Sunil K. Joshi, Jeffrey Tyner, Ujwal Shinde, Ariane Huang, Marina Gritsenko, Karin Rodland, Kevin Watanabe‐Smith, Sara J.C. Gosline, Chelsea Hutchinson
article en

Abstract

No abstract available for this paper.
HaematologicaVol. 110(7)
Pacific Northwest National Laboratory (US), Oregon Health & Science University (US), Environmental Molecular Sciences Laboratory (US), Stanford University (US)
Openalex Percentile: Top 96%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.